Blood derivatives manufacturing · North Carolina

Cellectis Biologics Inc.

Raleigh, NC · ~54 workers · 5 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.5
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Cellectis Biologics Inc. runs at 16% of its industry's injury rate - far safer than the typical Blood derivatives manufacturing workplace, earning a grade A.

Cellectis Biologics Inc.: 0.5 TCR = 16% of Blood derivatives manufacturing BLS 3.3 · 5y Form 300A (see methodology below)

Cellectis Biologics Inc. safety composite

Cellectis Biologics Inc. scores strongest on dart rate (safer than 83% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

C

73/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
B 0.53 per 100 workers

Safer than 78% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

Cellectis Biologics Inc.: 0.0 → 1.2 TCR

Peak year 2021 @ 1.4 TCR · DART/TCR 0× in 2024

Cellectis Biologics Inc.'s TCR rose 1.2 from 0.0 in 2020 to 1.2 in 2024. Peak filing year was 2021 at 1.4 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325414 · Raleigh, NC AT/BELOW-IND · SMALL

Grade A · TCR 0.5 · 16% of ind

  • DART 0.0 DART
  • RANK #8/16
  • PHOTO Novartis GTx Durham
  • BOOK 5y book
  • INJ 2 inj
  • SIZE ~54 FTE

Nearest TCR peer: Novartis GTx Durham (0.0 TCR gap)

Read with this employer → · Industry book → · North Carolina employers → · Look up another →

Cellectis Biologics Inc. in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Cellectis Biologics Inc. averages 0.5 TCR (16% of the Blood derivatives manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Cellectis Biologics Inc. TCR series: 2020=0 · 2021=1.4 · 2022=0 · 2023=0 · 2024=1.2 · BLS 3.3

Where Cellectis Biologics Inc. falls in its industry

234 Blood derivatives manufacturin establishments

Safer than 78% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to North Carolina alone (the establishments it most directly competes with for workers and contracts): ranked #8 safest of 16 Blood derivatives manufacturin employers in North Carolina.

Cellectis Biologics Inc. (54 employees, TCR 0.5) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Cellectis Biologics Inc.
Cellectis Biologics Inc. (54 employees, TCR 0.5) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Cellectis Biologics Inc. has fewer employees than the Blood derivatives manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 1.2 0.0 1 0 0
2023 0.0 0.0 0 0 0
2022 0.0 0.0 0 0 0
2021 1.4 1.4 1 0 0
2020 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · NC · Raleigh

234 Blood derivatives manufacturing employers nationwide with a credible TCR · 16,981 rated employers in North Carolina with headcount on file · 973 employers in Raleigh, NC · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Novartis GTx Durham 0.5 TCR
NAICS-TCR Merck Teknika Facility 0.5 TCR
NAICS-TCR Spark Therapeutics, Inc 0.5 TCR
NAICS-TCR Zoetis LLC. 0.5 TCR
STATE-SIZE ER LEWIS CONSTRUCTION CO, INC. 54 FTE
STATE-SIZE Elizabethtown 54 FTE
STATE-SIZE D.R. Horton, Inc. - Raleigh North 54 FTE
STATE-SIZE Mundy Maintenance and Services LLC Job #31045 54 FTE
CITY-NEAR Headway Workforce Solutions 13,936 FTE
CITY-NEAR NC State University 11,491 FTE
CITY-NEAR UNC Rex Healthcare 7,282 FTE
CITY-NEAR SECU 6,283 FTE
NAT-TCR Chemetall US Inc. 0.5 TCR
NAT-TCR Old Hickory Management 0.5 TCR
NAT-TCR Standard Solar, Inc. 0.5 TCR
NAT-TCR Strategic Industry Inc 0.5 TCR
NAT-SIZE Cemplex Group Florida, LLC 54 FTE
NAT-SIZE tkSCS Toledo Matzinger 54 FTE
NAT-SIZE The Residence at Voorhees 54 FTE
NAT-SIZE LaGrou Rana 54 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2021, 2020. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.